Quantcast

Prairie State Wire

Monday, May 12, 2025

FDA conducted second lowest number of inspections on Biologics companies in Illinois during Q1

Webp wpqolpnrcij8e8mt9jfg90exrory

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

In the first quarter of 2025, four Biologics companies received four FDA inspections in Illinois, according to the U.S. Food and Drug Administration (FDA).

This was the second lowest number of inspections per type of company made by the FDA in Illinois, equalling 11.1% of all inspections in the first quarter of 2025.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in Illinois During Q1
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products4
Compliance: Devices41
Drug Quality Assurance1
Food Composition, Standards, Labeling and Econ4
Foodborne Biological Hazards1641
Monitoring of Marketed Animal Drugs, Feed, and Devices5
Postmarket Assurance: Devices4
Technical Assistance: Food and Cosmetics1

MORE NEWS